Impact of COVID-19 Outbreak on Liver Diseases Therapeutics Market : Trend, CAGR Status, Growth, Analysis and Forecast to 2025 : Gilead Science, Bayer, AstraZeneca, Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, F. Hoffmann-La Roche, and Novartis
The global liver diseases therapeutics market is projected to grow at a CAGR of 6.3% over the forecast period of 2019-2025.
View full press release